Thus, high-profile studies investigating feasibility of the modality in terms of adverse effects seem premature.doi:10.1038/nrurol.2012.133GuillonneauBertrandNature Reviews UrologyGuillonneau B. Prostate cancer: New treatments for localized tumours—what matters first? Nat Rev Urol. 2012; 9 :414–5....
In the realm of medical advancements, the treatment of prostate cancer, a significant health concern for middle-aged men, has seen remarkable progress. This article, tailored for students from elementary to high school, aims to educate you on the basics of prostate cancer, new therapies, and ho...
Professor Saatcioglu and an international group of research partners demonstrated in 2015 both one signal path that is activated and another that is inhibited inprostate cancer cells, thus they began to study the activated signal path—with the term IRE1. It has not previously been known that t...
In recent years the pace of research in prostate cancer has increased dramatically. Creative ideas in combination with new and emerging technologies have led to an explosion of discovery. These types of advances in prostate cancer research presage an era of new treatment strategies based on an unde...
New treatments for localized tumours—what matters first?doi:10.1038/nrurol.2012.133B. GuillonneauNature Reviews Urology
LHRH agonists have also been used prior to or following various local treatments in patients with clinically localised prostate cancer and at high risk for disease recurrence [5]. Thus indications for the treatment with LHRH agonists include, besides T3 metastatic prostate cancer, patients with rising...
an assistant professor at the Rutgers School of Health Professions and research member at Rutgers Cancer Institute of New Jersey. "Our results show that molecular profiling at the time of diagnosis can help inform more personalized therapy leading to better outcomes for those with this advanced form...
Current state of the art, multimodality research and future visions for the treatment of patients with prostate cancer: consensus results from "Challenges ... A brainstorming and consensus meeting organized by the German Cancer Aid focused on modern treatment of prostate cancer and promising innovative...
New method examines the genetic background of tumors for more effective prostate cancer therapy. Different approaches for deciphering genetic data could result in new prostate cancer treatments, a recent study suggests. Research has been increasingly driven towards personalized medicine or therapies that ...
- 《Cancer Research》 被引量: 0发表: 2004年 Transrectal high-intensity focused ultrasound for the treatment of localized prostate cancer: eight-year experience. Objective: To report on the long-term results of high-intensity focused ultrasound in the treatment of localized prostate cancer. Methods:...